Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 6, no: 0 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A0A3S7WNP1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 210 | 214 | PF00656 | 0.677 |
CLV_C14_Caspase3-7 | 235 | 239 | PF00656 | 0.677 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.440 |
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.604 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.660 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.610 |
CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.653 |
CLV_PCSK_PC1ET2_1 | 183 | 185 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.611 |
DEG_SPOP_SBC_1 | 121 | 125 | PF00917 | 0.397 |
DOC_MAPK_RevD_3 | 169 | 184 | PF00069 | 0.416 |
DOC_PP2B_LxvP_1 | 21 | 24 | PF13499 | 0.450 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.411 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.419 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.373 |
LIG_14-3-3_CanoR_1 | 83 | 88 | PF00244 | 0.338 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.508 |
LIG_BRCT_BRCA1_1 | 219 | 223 | PF00533 | 0.652 |
LIG_BRCT_BRCA1_1 | 26 | 30 | PF00533 | 0.344 |
LIG_deltaCOP1_diTrp_1 | 82 | 88 | PF00928 | 0.449 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.398 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.364 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.416 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.471 |
LIG_LIR_Apic_2 | 148 | 153 | PF02991 | 0.568 |
LIG_LIR_Gen_1 | 27 | 36 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 82 | 90 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 115 | 120 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 133 | 138 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 203 | 207 | PF02991 | 0.713 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.443 |
LIG_LYPXL_yS_3 | 138 | 141 | PF13949 | 0.442 |
LIG_SH2_CRK | 150 | 154 | PF00017 | 0.502 |
LIG_SH2_GRB2like | 135 | 138 | PF00017 | 0.476 |
LIG_SH2_GRB2like | 144 | 147 | PF00017 | 0.418 |
LIG_SH2_GRB2like | 78 | 81 | PF00017 | 0.447 |
LIG_SH2_NCK_1 | 150 | 154 | PF00017 | 0.567 |
LIG_SH2_SRC | 78 | 81 | PF00017 | 0.447 |
LIG_SH2_STAP1 | 53 | 57 | PF00017 | 0.473 |
LIG_SH2_STAT3 | 144 | 147 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.276 |
LIG_SUMO_SIM_anti_2 | 161 | 167 | PF11976 | 0.420 |
LIG_TYR_ITSM | 113 | 120 | PF00017 | 0.349 |
LIG_Vh1_VBS_1 | 164 | 182 | PF01044 | 0.416 |
LIG_WRC_WIRS_1 | 30 | 35 | PF05994 | 0.434 |
MOD_CDK_SPxxK_3 | 148 | 155 | PF00069 | 0.569 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.513 |
MOD_CK1_1 | 195 | 201 | PF00069 | 0.726 |
MOD_CK1_1 | 203 | 209 | PF00069 | 0.670 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.624 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.693 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.711 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.721 |
MOD_Cter_Amidation | 153 | 156 | PF01082 | 0.711 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.631 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.638 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.483 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.623 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.430 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.369 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.710 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.673 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.671 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.634 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.764 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.450 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.462 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.372 |
MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.564 |
MOD_N-GLC_1 | 145 | 150 | PF02516 | 0.702 |
MOD_N-GLC_1 | 200 | 205 | PF02516 | 0.500 |
MOD_N-GLC_1 | 214 | 219 | PF02516 | 0.478 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.559 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.701 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.405 |
MOD_PIKK_1 | 100 | 106 | PF00454 | 0.423 |
MOD_PIKK_1 | 232 | 238 | PF00454 | 0.675 |
MOD_PIKK_1 | 40 | 46 | PF00454 | 0.428 |
MOD_PKA_1 | 226 | 232 | PF00069 | 0.801 |
MOD_PKA_1 | 68 | 74 | PF00069 | 0.394 |
MOD_PKA_1 | 83 | 89 | PF00069 | 0.388 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.710 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.332 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.447 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.744 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.570 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.369 |
MOD_SUMO_rev_2 | 66 | 71 | PF00179 | 0.323 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.336 |
TRG_ER_diArg_1 | 83 | 85 | PF00400 | 0.410 |
TRG_NLS_MonoExtC_3 | 182 | 188 | PF00514 | 0.652 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBW5 | Leptomonas seymouri | 38% | 83% |
A4H3V9 | Leishmania braziliensis | 66% | 100% |
A4HS33 | Leishmania infantum | 99% | 100% |
E9AK20 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q9XZX6 | Leishmania major | 91% | 100% |